A multidisciplinary consensus statement on the optimal pharmacological treatment for metastatic hormone-sensitive prostate cancer A. Borque-Fernando; M.A. Calleja-Hernández; J.M. Cózar-Olmo; A. Gómez-Iturriaga; D.A. Pérez-Fentes; J. Puente-Vázquez; M. Rodrigo-Aliaga; M. Unda; J.L. Álvarez-Ossorio;

Prior MRI-imaging impact of patients submitted to brachytherapy for prostate cancer D. Vieira e Brito; A. Fereira; J. Pereira; M. Pereira-Lourenço; R. Godinho; B. Pereira; P. Peralta; P. Conceiçao; A. Reis Mario; C. Paula Rabaça;

European Association of Urology biochemical recurrence risk groups after radical prostatectomy: External validation and identification of independent risk factors for progression and death R. Sopeña Sutil; D. Vázquez-Martul; P. De Pablos-Rodríguez; E. Peña Vallejo; C. Altez Fernández; A. Gómez-Ferrer Lozano; J. Téigell Tobar; G. Rollón Prieto; A. Coy García; M. Ramírez Backhaus; V. Chantada Abal; A. Rodríguez Antolín;